You have   6 free profiles   left this month    Start Your Free Trial ➤
Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there? View on RelSci Pro ➤

Fredric N. Eshelman

Chief Executive Officer at Innocrin Pharmaceuticals, Inc.
Relationship Science aggregates deep and verified information on over 6 million influential decision makers and the 2 million organizations with which they are associated. From this data, we create a "business social graph" that highlights who knows whom. Here are Fredric N. Eshelman's strongest connections.

People Most Closely Connected to Fredric N. Eshelman

Click the names below to expand relationship details.
William R. Moore, Jr.
President at Innocrin Pharmaceuticals, Inc.
S. Edward Torres
Co-Founder & Managing Director at Lilly Ventures Management Co.
Sailash I. Patel
Chief Executive Officer & Director at Meryx, Inc.
Douglas Reed
General Partner at Hatteras Venture Partners
Kristopher A. Wood
CIO at Lurie Investments
Richard S. Kent
President at Maverick Label
Robert J. Schotzinger
President & Chief Executive Officer at Viamet Pharmaceuticals Corp.
Steven D. Weinstein
Managing Director at Novartis Venture Fund
Andrew C. von Eschenbach
Vice President Revenue Cycle at Trinity Mother Frances Health System
Ebrahim Versi
Co-Founder at Dignify Therapeutics
Sean Ianchulev
President & Chief Executive Officer at Eyenovia, Inc.
Daniel J. Ricca
Co-Founder at Dignify Therapeutics
Chad Roy
Chief Executive Officer & Director at Asepticys
Thomas F. Tedder
Chief Executive Officer & Director at Cellective Biotherapy, Inc.
Stuart O. Bondurant
Former Dean of the School of Medicine at The University of North Carolina at Chapel Hill
Ernest Mario
Venture Partner at Pappas Capital
Charles F. Osborne, Jr.
Chief Financial Officer & Secretary at Innocrin Pharmaceuticals, Inc.
Karl B. Thor
Founder at Dignify Therapeutics
There are 1,677 more people accessible only with RelSci Professional.